CareLit · DOI-Nachweis · Klinische Pädiatrie
Inhibiting the PI3K/Akt/mTOR pathway in combination with conventional chemotherapy as a new treatment option for GBM patients
DOI 10.1055/s-0030-1254477
Bibliografische Angaben
Nachweis in CareLit
Autor:innenL Nonnenmacher, MA Westhoff, KM Debatin, S Corbacioglu, S Fulda
ZeitschriftKlinische Pädiatrie
Ausgabe05/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Despite intense research into therapeutic options for GBM patients, their life expectancy has remained dismal for the last twenty years. Within the context of a multidisciplinary clinical study we evaluate novel therapeutic approaches for treatment of glioblastoma, combining conventional chemotherapy with pharmacological inhibitors that block various components of the PI3K/Akt/mTOR signaling cascade. M…
Zitieren
Zitierempfehlung
L Nonnenmacher, MA Westhoff, KM Debatin, S Corbacioglu, S Fulda (2010) Inhibiting the PI3K/Akt/mTOR pathway in combination with conventional chemotherapy as a new treatment option for GBM patients. Klinische Pädiatrie (05). https://doi.org/10.1055/s-0030-1254477
Mit CareLit weiterarbeiten